AngioDynamics (ANGO)
(Delayed Data from NSDQ)
$6.27 USD
+0.19 (3.13%)
Updated May 3, 2024 04:00 PM ET
After-Market: $6.27 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.27 USD
+0.19 (3.13%)
Updated May 3, 2024 04:00 PM ET
After-Market: $6.27 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum F VGM
Zacks News
AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Despite strength in the Med Tech business, AngioDynamics (ANGO) registers overall soft performance in third-quarter fiscal 2024.
AngioDynamics' (ANGO) AlphaVac Gets FDA Nod for PE Treatment
by Zacks Equity Research
AngioDynamics (ANGO) announces the FDA's approval of its AlphaVac F1885 System, which is likely to expand the range of therapy alternatives available to pulmonary embolism patients.
AngioDynamics (ANGO) Settles Patent Litigations With BD
by Zacks Equity Research
AngioDynamics (ANGO) announces its settlement agreement with BD's affiliate, C.R. Bard, to resolve a 10-year dispute over outstanding patent litigation.
Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
AngioDynamics (ANGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AngioDynamics (ANGO) Declines More Than Market: Some Information for Investors
by Zacks Equity Research
In the most recent trading session, AngioDynamics (ANGO) closed at $5.37, indicating a -0.74% shift from the previous trading day.
Why AngioDynamics (ANGO) Dipped More Than Broader Market Today
by Zacks Equity Research
In the most recent trading session, AngioDynamics (ANGO) closed at $5.67, indicating a -1.39% shift from the previous trading day.
AngioDynamics (ANGO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
AngioDynamics (ANGO) closed the most recent trading day at $5.50, moving +0.18% from the previous trading session.
Here's Why AngioDynamics (ANGO) Gained But Lagged the Market Today
by Zacks Equity Research
In the most recent trading session, AngioDynamics (ANGO) closed at $5.99, indicating a +1.7% shift from the previous trading day.
AngioDynamics (ANGO) Divests Its PICC & Midline Businesses
by Zacks Equity Research
AngioDynamics (ANGO) finalizes its PICC and Midline businesses divestment to Spectrum Vascular to optimize its product portfolio and to focus on strengthening its med tech segment.
Why AngioDynamics (ANGO) Outpaced the Stock Market Today
by Zacks Equity Research
AngioDynamics (ANGO) closed at $6.17 in the latest trading session, marking a +1.31% move from the prior day.
AngioDynamics (ANGO) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
The latest trading day saw AngioDynamics (ANGO) settling at $6.09, representing a -0.98% change from its previous close.
AngioDynamics' (ANGO) New XL Catheter to Help in PAD Treatment
by Zacks Equity Research
AngioDymics' (ANGO) new FDA-approved Auryon XL Catheter is likely to boost PAD treatment by eliminating access site complications in Atherectomy procedures.
AngioDynamics (ANGO) Q2 Earnings Top Estimates, Revenues Miss
by Zacks Equity Research
AngioDynamics (ANGO) registers strong revenue growth in the Med Tech business in second-quarter fiscal 2024.
AngioDynamics (ANGO) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
AngioDynamics (ANGO) delivered earnings and revenue surprises of 44.44% and 3.15%, respectively, for the quarter ended November 2023. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
AngioDynamics (ANGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why AngioDynamics (ANGO) Outpaced the Stock Market Today
by Zacks Equity Research
The latest trading day saw AngioDynamics (ANGO) settling at $7.63, representing a +1.87% change from its previous close.
AngioDynamics (ANGO) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
AngioDynamics (ANGO) closed at $6.91 in the latest trading session, marking a -0.72% move from the prior day.
AngioDynamics (ANGO) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
AngioDynamics (ANGO) closed the most recent trading day at $6.77, moving -1.31% from the previous trading session.
CVRx (CVRX) Moves 7.1% Higher: Will This Strength Last?
by Zacks Equity Research
CVRx (CVRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AngioDynamics (ANGO) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
In the most recent trading session, AngioDynamics (ANGO) closed at $6.74, indicating a -0.15% shift from the previous trading day.
AngioDynamics (ANGO) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
AngioDynamics (ANGO) closed the most recent trading day at $6.85, moving +1.33% from the previous trading session.
AngioDynamics (ANGO) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
In the latest trading session, AngioDynamics (ANGO) closed at $6.86, marking a -1.15% move from the previous day.
AngioDynamics (ANGO) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
In the closing of the recent trading day, AngioDynamics (ANGO) stood at $6.21, denoting a +0.65% change from the preceding trading day.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
AngioDynamics (ANGO) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
AngioDynamics (ANGO) registers strong revenue growth in the Med Tech business in first-quarter fiscal 2024.